Study Stopped
In process (technical improvements)
TICOP Mobile App and E-platform: Providing Information and Support for Parents Caring for Their Child Cancer Survivor
TICOP
Digital Technology for Parents in Pediatric Oncology: Development and Implementation
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This study aims to develop a mobile App (named "TICOP") for parents of a childhood cancer survivor and an E-Platform for health professionals which work in pediatric oncology area. The core objective is to evaluate the effects of these two digital tools (mobile app and platform) in the detection and prevention among parents of a childhood cancer survivor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2019
CompletedFirst Posted
Study publicly available on registry
May 10, 2019
CompletedStudy Start
First participant enrolled
May 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2025
CompletedDecember 11, 2023
December 1, 2023
3.5 years
May 3, 2019
December 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Psychological symptoms (created for the needs of the study)
13 items ranged between 0% at 100% \[Visual Analog Scale\] Scale range : 0 = rarely; 1 = occasionally ; 2 = often; 3 = mostly Note. Results are significant when the score is above 25% for one single item with at least two occurrences over time period.
Measure assessing change between four time points (change from Baseline at 4 months, 8 months and 12 months)
Psychosomatic symptoms (created for the needs of the study)
16 items ranged between 0% at 100% \[Visual Analog Scale\] Scale range : 0 = rarely; 1 = occasionally ; 2 = often; 3 = mostly Note. Results are significant when the score is above 25% for one single item with at least two occurrences over time period.
Measure assessing change between four time points (change from Baseline at 4 months, 8 months and 12 months)
Parental needs (created for the needs of the study)
9 items ranged between 0% at 100% \[Visual Analog Scale\]
Measure assessing change between four time points (change from Baseline at 4 months, 8 months and 12 months)
Parental resources (created for the needs of the study)
8 items ranged between 0% at 100% \[Visual Analog Scale\]
Measure assessing change between four time points (change from Baseline at 4 months, 8 months and 12 months)
Parental risk factors (created for the needs of the study)
5 paired-items ranged between 0% at 100% \[Visual Analog Scale\] Note. Results are significant when the score is above 25% for one single item with at least two occurrences over time period.
Measure assessing change between four time points (change from Baseline at 4 months, 8 months and 12 months)
Parental protective factors (created for the needs of the study)
6 paired-items ranged between 0% at 100% \[Visual Analog Scale\] Note. Results are significant when the score is above 25% for one single item with at least two occurrences over time period.
Measure assessing change between four time points (change from Baseline at 4 months, 8 months and 12 months)
Sociodemographic questionnaire (parents of a childhood cancer survivor) (created for the needs of the study)
14 items (multiple-choice response)
Baseline
Study Arms (1)
8 parents of a childhood cancer survivor
EXPERIMENTALParent moves the cursor by analogy on their mobile phone (as a visual anagogic scale) four times per year (baseline; month 4; month 8 and month 12).
Interventions
Parent moves the cursor by analogy on their mobile phone (as a visual anagogic scale) four times per year (baseline; month 4; month 8 and month 12).
Eligibility Criteria
You may qualify if:
- Parent of a childhood cancer survivor (mother and father)
- Child who had been diagnosed in remission since 1 years until 10 years (without relapse)
- Neoadjuvant chemotherapy during treatments
- Fluency in French speaking
- No previous evidence of mental illness.
You may not qualify if:
- Diagnosis of cancer treated only by surgery or radiotherapy (with no adjuvant chemotherapy)
- Benign tumor
- Child has a relapse or died
- Non-French-speaking parents
- previous evidence of mental illness.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Liège (Unit: Health Psychology)
Liège, 4000, Belgium
Related Publications (3)
Vander Haegen M, Etienne AM. Intolerance of uncertainty in parents of childhood cancer survivors: A clinical profile analysis. J Psychosoc Oncol. 2018 Nov-Dec;36(6):717-733. doi: 10.1080/07347332.2018.1499692. Epub 2018 Nov 14.
PMID: 30427278BACKGROUNDVander Haegen M, Etienne AM. Intolerance of uncertainty as the vulnerability factor among parents of childhood cancer survivors: A 3-month follow-up study. J Psychosoc Oncol. 2018 Jul-Aug;36(4):437-453. doi: 10.1080/07347332.2018.1443192. Epub 2018 May 14.
PMID: 29757114BACKGROUNDVander Haegen M, Luminet O. Stress, Psychosocial Mediators, and Cognitive Mediators in Parents of Child Cancer Patients and Cancer Survivors: Attention and Working Memory Pathway Perspectives. J Psychosoc Oncol. 2015;33(5):504-50. doi: 10.1080/07347332.2015.1067279.
PMID: 26181302BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Marie Vander Haegen, Dr.
University of Liege
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Doctor of Psychology (Ph.D) (Uliège)
Study Record Dates
First Submitted
May 3, 2019
First Posted
May 10, 2019
Study Start
May 15, 2019
Primary Completion
November 2, 2022
Study Completion
May 15, 2025
Last Updated
December 11, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share